Close Menu

I Want My DNA!

Writing in the New Scientist, Daniel MacArthur and Caroline Wright say that when it comes to DTC genetic testing, they "believe that regulation is needed, but are worried that it will focus too heavily on 'protecting' consumers from their own genomes." The authors note that once "lauded" as Time's invention of the year, personal genome scans have had a hard time "living up to that promise," and consequently their medical value has been limited. But, MacArthur and Wright say, not all DTC companies hold themselves to the same standards.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.